The analytical sensitivity of the cobas EGFR test for exon 19 deletion, L858R, S768I, T790M, G719X, and exon 20 insertion mutations was assessed using NSCLC FFPET-derived DNA blends and six plasmid DNA blends. This evidence concerns the gene EGFR and non-small cell lung carcinoma.